School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Twist Bioscience Corp TWST

Healthcare · Biotechnology

$159.78last close 2026-10-09 · market cap $10.52B · delayed data

Trailing returns

1M+27.29%
3M+70.58%
6M+227.15%
1Y+401.03%
5Y+62.13%

Basis: Adjusted daily closes.

What it does

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. It offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS…

Open TWST in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies